Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: A 3-year retrospective longitudinal study

Journal of Bone and Mineral Research

Volumn 27, Issue 11, 2012, Pages 2279-2290

  Kim, Beom Jun ^a   Ahn, Seong Hee ^a   Bae, Sung Jin ^a   Kim, Eun Hee ^a   Lee, Seung Hun ^a   Kim, Hong Kyu ^a   Choe, Jae Won ^a   Koh, Jung Min ^a   Kim, Ghi Su ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

BONE LOSS; BONE MINERAL DENSITY; FERRITIN; IRON OVERLOAD

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCIUM; CREATININE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHORUS; TRANSFERRIN; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; BONE DENSITY; BONE MASS; BONE METABOLISM; DAIRY PRODUCT; DIASTOLIC BLOOD PRESSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FEMUR NECK; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON OVERLOAD; IRON STORAGE; KOREA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; SPINE FRACTURE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CONFIDENCE INTERVALS; FEMALE; FEMUR; FERRITINS; HEALTH; HUMANS; IRON OVERLOAD; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; REGRESSION ANALYSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84865208678     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1692     Document Type: Article

References (39)

1. Crichton RR, Wilmet S, Legssyer R, Ward RJ., Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem. 2002; 91: 9-18. (Pubitemid 34727756)
2. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV., Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med. 1988; 318: 809-14. (Pubitemid 18083628)
3. Pietrangelo A., Hereditary hemochromatosis-a new look at an old disease. N Engl J Med. 2004; 350: 2383-97.
4. Yamasaki K, Hagiwara H., Excess iron inhibits osteoblast metabolism. Toxicol Lett. 2009; 191: 211-5.
5. Yang Q, Jian J, Abramson SB, Huang X., Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis. J Bone Miner Res. 2011; 26: 1188-96.
6. Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, Ikeda K., Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med. 2009; 15: 259-66.
7. Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giardina PJ, Boskey AL, Vogiatzi MG., Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood. 2010; 116: 2582-9.
8. Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Lane J, Schneider R, Fleisher M, Grady RW, Peterson CC, Giardina PJ., Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res. 2009; 24: 543-57.
9. Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y, Chales G., Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int. 2005; 16: 1809-14. (Pubitemid 41790893)
10. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB., Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004; 291: 711-7. (Pubitemid 38543791)
11. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM., Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J. 2000; 140: 98-104. (Pubitemid 30471247)
12. Zarjou A, Jeney V, Arosio P, Poli M, Zavaczki E, Balla G, Balla J., Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res. 2010; 25: 164-72.
13. Halle M, Konig D, Berg A, Keul J, Baumstark MW., Relationship of serum ferritin concentrations with metabolic cardiovascular risk factors in men without evidence for coronary artery disease. Atherosclerosis. 1997; 128: 235-40. (Pubitemid 27092158)
14. Yeh ET, Willerson JT., Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003; 107: 370-1.
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112: 2735-52. (Pubitemid 41532612)
16. Kiel D., Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. J Bone Miner Res. 1995; 10: 518-23.
17. Black DM, Palermo L, Nevitt MC, Genant HK, Christensen L, Cummings SR., Defining incident vertebral deformity: a prospective comparison of several approaches. J Bone Miner Res. 1999; 14: 90-101. (Pubitemid 29021608)
18. Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA., High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet. 1999; 354: 971-5. (Pubitemid 29438401)
19. Arabi A, Baddoura R, El-Rassi R, El-Hajj Fuleihan G., PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Osteoporos Int. 2012; 23: 971-80.
20. Gabay C, Kushner I., Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340: 448-54. (Pubitemid 29084777)
21. Jehn M, Clark JM, Guallar E., Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care. 2004; 27: 2422-8. (Pubitemid 39281396)
22. Fernandez-Real JM, Ricart-Engel W, Arroyo E, Balanca R, Casamitjana-Abella R, Cabrero D, Fernandez-Castaner M, Soler J., Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care. 1998; 21: 62-8. (Pubitemid 28030387)
23. McCord JM., Effects of positive iron status at a cellular level. Nutr Rev. 1996; 54: 85-8. (Pubitemid 26176136)
24. Andrews NC., Disorders of iron metabolism. N Engl J Med. 1999; 341: 1986-95. (Pubitemid 30010408)
25. Wilson JG, Lindquist JH, Grambow SC, Crook ED, Maher JF., Potential role of increased iron stores in diabetes. Am J Med Sci. 2003; 325: 332-9. (Pubitemid 36712655)
26. Salonen JT, Tuomainen TP, Nyyssonen K, Lakka HM, Punnonen K., Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ. 1998; 317: 727. (Pubitemid 28414303)
27. Piperno A, Trombini P, Gelosa M, Mauri V, Pecci V, Vergani A, Salvioni A, Mariani R, Mancia G., Increased serum ferritin is common in men with essential hypertension. J Hypertens. 2002; 20: 1513-158.
28. Gillum RF., Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men-the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord. 2001; 25: 639-45. (Pubitemid 32417632)
29. Sinigaglia L, Fargion S, Fracanzani AL, Binelli L, Battafarano N, Varenna M, Piperno A, Fiorelli G., Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol. 1997; 24: 1809-13. (Pubitemid 27394522)
30. Kasai K, Hori MT, Goodman WG., Characterization of the transferrin receptor in UMR-106-01 osteoblast-like cells. Endocrinology. 1990; 126: 1742-9. (Pubitemid 20095787)
31. Messer JG, Kilbarger AK, Erikson KM, Kipp DE., Iron overload alters iron-regulatory genes and proteins, down-regulates osteoblastic phenotype, and is associated with apoptosis in fetal rat calvaria cultures. Bone. 2009; 45: 972-9.
32. Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, Kim GS., Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int. 2005; 16: 1263-71. (Pubitemid 41396955)
33. Green S, Anstiss CL, Fishman WH., Automated differential isoenzyme analysis. II. The fractionation of serum alkaline phosphatases into "liver", "intestinal" and "other" components. Enzymologia. 1971; 41: 9-26.
34. van Straalen JP, Sanders E, Prummel MF, Sanders GT., Bone-alkaline phosphatase as indicator of bone formation. Clin Chim Acta. 1991; 201: 27-33.
35. Kim CH, Kim HK, Bae SJ, Park JY, Lee KU., Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism. 2011; 60: 414-20.
36. Pouilles JM, Tremollieres F, Ribot C., The effects of menopause on longitudinal bone loss from the spine. Calcif Tissue Int. 1993; 52: 340-3. (Pubitemid 23124828)
37. Pouilles JM, Tremollieres F, Ribot C., Effect of menopause on femoral and vertebral bone loss. J Bone Miner Res. 1995; 10: 1531-6.
38. Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse R, Kreiger N, Tenenhouse A, Goltzman D., Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ. 2008; 178: 1660-8. (Pubitemid 351897981)
39. Jones G, Nguyen T, Sambrook P, Kelly PJ, Eisman JA., Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ. 1994; 309: 691-5. (Pubitemid 24285219)